Rabbit Anti Influenza A Neuraminidase (H1N1-NA) antiserum |
H1N1NA11-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Human IgG antibody Laboratories manufactures the influenza a h1n1 neuraminidase (na): influenza n1 antibody reagents distributed by Genprice. The Influenza A H1N1 Neuraminidase (Na): Influenza N1 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Influenza products are available in stock. Specificity: Influenza Category: A Group: H1N1 Neuraminidase
Influenza-A H1N1 Antibody |
Abbexa |
-
EUR 1128.00
-
EUR 393.60
-
EUR 276.00
|
|
|
Influenza-A H1N1 Antibody |
Abbexa |
-
EUR 276.00
-
EUR 2148.00
-
EUR 393.60
|
|
|
Influenza A N1 Antibody |
Abbexa |
100 ug |
EUR 1011.6 |
|
H1N1 Neuraminidase Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
H1N1 Neuraminidase Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
H1N1 Neuraminidase Antibody |
SAB |
100ul |
EUR 468 |
Influenza A (Swine H1N1) Neuraminidase (A/California/14/2009) Peptide |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A (Swine H1N1) Neuraminidase (A/California/14/2009) Peptide |
H1N1 Neuraminidase information
Avian Influenza Neuraminidase Antibody |
24275-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Neuraminidase Antibody |
3421-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3423-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3423-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3421-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Recombinant (E.coli, His-tag) purified Influenza A Neuraminidase (H1N1-NA) protein (>95%) |
H1N1NA15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Influenza A H5N1 (Avian) Neuraminidase, C-Terminal Peptide |
11-560 |
ProSci |
0.05 mg |
EUR 632.4 |
Description: Influenza A H5N1 (Avian) Neuraminidase, C-Terminal Peptide |
Polyclonal Avian Influenza Neuraminidase Antibody |
APR11000G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza Neuraminidase . This antibody is tested and proven to work in the following applications: |
Polyclonal Avian Influenza Neuraminidase Antibody |
APR11001G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza Neuraminidase . This antibody is tested and proven to work in the following applications: |
Influenza A virus Neuraminidase Recombinant Protein |
96-372 |
ProSci |
0.1 mg |
EUR 682.8 |
Description: Neuraminidase (NA) and hemagglutinin (HA) are major membrane glycoproteins found on the surface of influenza virus. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle. Neuraminidase, on the other hand, cleaves the HA-sialic acid bondage from the newly formed virions and the host cell receptors during budding. Neuraminidase thus is described as a receptor-destroying enzyme which facilitates virus release and efficient spread of the progeny virus from cell to cell. |
Influenza Neuraminidase Inhibitor Susceptibility Assay Kit |
K524-1000 |
Biovision |
each |
EUR 744 |
Influenza A H1N1 antibody |
10R-7791 |
Fitzgerald |
50 ug |
EUR 678 |
Description: Mouse monoclonal Influenza A H1N1 antibody |
Influenza A antibody (H1N1) |
20-IG23 |
Fitzgerald |
1 mg |
EUR 139.2 |
Description: Goat polyclonal Influenza A antibody (H1N1) |
Influenza A antibody (H1N1) |
20C-CR1233GP |
Fitzgerald |
1 ml |
EUR 511.2 |
Description: Goat polyclonal Influenza A antibody (H1N1) |
Influenza A H1N1 Antibody |
abx023045-100ug |
Abbexa |
100 ug |
EUR 1011.6 |
|
Influenza A H1N1 Antibody |
abx023046-100ug |
Abbexa |
100 ug |
EUR 961.2 |
|
Influenza-A H1N1 Antibody |
20-abx137503 |
Abbexa |
-
EUR 1128.00
-
EUR 393.60
-
EUR 276.00
|
|
|